Pandemic must reorient Canada’s pharmaceutical policy away from market-based approach
The federal government should immediately re-establish a public drug and vaccine manufacturer in Canada. This would ensure a resilient domestic supply capacity in the event of future public health emergencies and shortages.
Health Minister Patty Hajdu, pictured during a press briefing on the pandemic. Prime Minister Justin Trudeau has blamed the hollowing out of Canada’s bio-manufacturing sector on his Conservative predecessors, but the situation country faces has been decades in the making. The Hill Times photograph by Andrew Meade